Pathogen Detection Using Sample Metadata and Molecular Signatures

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current animal health diagnostics lack a systemic approach for efficiently evaluating and identifying harmful agents, such as pathogens, to enable early intervention or prevention, often relying on limited, disease-specific panels that do not leverage genomic sequence or combinatorial information for comprehensive pathogenic burden analysis.

Innovation Solution

A system integrating automated assay design, multiplexed genomic sequencing, intelligent databases, and AI/ML for real-time analysis of biological and environmental data to detect, identify, and predict pathogens, generating actionable intelligence reports.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If comprehensive genomic sequencing and AI/ML analysis are implemented, then pathogen identification accuracy and speed are improved, but system complexity and cost increase

Engineering Contradiction:
Improvepathogen identification accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system divides pathogen detection into multiple independent genomic regions (16S rRNA, ITS1, ITS2, 28S rRNA, etc.) that can be sequenced and analyzed separately. Each region targets specific taxonomic levels (bacteria, fungi, etc.), allowing comprehensive coverage while maintaining manageable analysis complexity through modular processing of discrete genomic segments.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces standardized metadata fields and structured data formats as intermediaries between sample collection and AI/ML analysis. These standardized interfaces (including sample metadata, sequencing metadata, and result metadata schemas) enable automated processing and reduce system complexity by providing uniform data structures that bridge different system components.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If multiple microorganisms are assayed simultaneously, then diagnostic comprehensiveness is improved, but analysis time and computational resources increase

Engineering Contradiction:
Improvediagnostic comprehensivenessVSAvoidanalysis time
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The system performs quality control checks, contamination assessments, and preliminary data validation steps before full AI/ML analysis. Metadata is collected and standardized in advance, and sequencing data is pre-processed and filtered to remove low-quality reads, reducing the computational burden and time required for the main pathogen identification analysis.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system implements a tiered analysis approach where essential pathogen identification is performed first using key genomic regions, followed by optional deeper analysis of additional regions if needed. This allows rapid initial diagnosis while providing the option for more comprehensive analysis when clinically indicated, balancing speed and comprehensiveness.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS12439892B2Systems and methods for identifying disease causing agents and interventions based on sample metadata and molecular signatures
Publication Date: 2025.10.14 SYMPHONY DIAGNOSTICS INC
  • US12439892B2 patent drawing
  • US12439892B2 patent drawing
  • US12439892B2 patent drawing

AI summary

Provided herein are systems and methods for animal health assessment, surveillance, and enhancement. For example, provided here are systems, devices, and processes that collect and analyze, in an efficient and high-throughput manner, biological information, environmental information, and demographic information about animal subjects to detect, identify, predict, and/or surveil adverse-health-causative or-associated agents, such as pathogens, and to select and identify suitable interventions.